NCT06903507

Brief Summary

The goal of this research is to determine if a new radiotherapy mattress is more comfortable for patients than the standard mattress. The table of the CT scanner and the radiation machine is flat and hard. To increase comfort during the CT scan and radiation dose delivery, the investigators have recently developed a new mattress (RTComfort). This research aims to find out if the new mattress is more comfortable for patients than the standard matt and to learn how radiotherapy mattresses can be further improved. Patients who participate in the research, will be asked to try both the standard mattress and the new mattress during the CT scan appointment. This will take about 5 minutes (one minute each). Patients will then be asked which mattress was most comfortable and if they experience any pain while lying on the mattress. Patients can choose which mattress will be used for the CT scan and treatment. Both mattresses are approved and safe for treatment. If patients participate in the research, it means the investigators will collect and use some of their (medical) data. Patients will not have any direct benefits from participating in this research, except that they can choose which mattress they want to lie on. Additionally, participation can help us gain more knowledge to make radiotherapy treatment more comfortable. Participation in the research will not affect the treatment. Participants will receive the normal treatment and check-ups for their condition. The drawback of participating is that the investigators will ask patients to try both mattresses, which will take about 5 minutes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 3, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 7, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 7, 2023

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

March 21, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 30, 2025

Completed
Last Updated

March 30, 2025

Status Verified

March 1, 2025

Enrollment Period

4 months

First QC Date

March 21, 2025

Last Update Submit

March 27, 2025

Conditions

Keywords

radiotherapypalliative radiotherapyradiation oncologycomfortpainmattressbone metastasis

Outcome Measures

Primary Outcomes (1)

  • The percentage of patients that prefered the newly developed comfort mattress over the standard thin foam matt

    The included patients tested the RT-Comfort Mattress and standard thin foam matt by lying on each for one minute in radiotherapy position, on the flat and hard CT scanner couch. Next, after patients identified their mattress or matt of choice, the treatment preparation and delivery were performed on their mattress or matt of choice according to standard clinical practice.

    Prior to radiotherapy planning-CT acquisition.

Secondary Outcomes (4)

  • The level preferrence of patients for the mattress of choice.

    Prior to radiotherapy planning-CT acquisition.

  • The pain patients experienced while lying on the comfort mattress and the standard thin foam matt, according to the 11-point Numerical Rating Scale (NRS).

    Prior to radiotherapy planning-CT acquisition, while lying on each mattress for one minute in treatment position.

  • The positioning stability of patients on the comfort mattress and the standard thin foam matt, measured with optical surface scanning

    During the first treatment fraction, the patients' surface scanning measurements were started directly after CBCT positioning verification and stopped directly after treatment dose delivery.

  • The dosimetrical effect of the RT-Comfort Mattress in the beam

    The dosimetrical effect was evaluated immediately after the radiotherapy treatment.

Study Arms (2)

RT-Comfort Mattress

EXPERIMENTAL

In this arm, the RT-Comfort Mattress was applied on top of the flat and hard radiotherapy treatment couch during planning CT acquisition and treatment dose delivery.

Device: RT-Comfort Mattress

Standard thin foam matt

NO INTERVENTION

For patients with painful bone metastasis, a standard thin foam matt is typically added on top of the flat and hard radiotherapy treatment couch to somewhat relief the pain. Unfortunately, this existing matt is too thin to effectively counter discomfort and pain.

Interventions

This dedicated RT-Comfort Mattress was newly developed (patent pending) for increasing comfort without compromising radiotherapy treatment quality.

RT-Comfort Mattress

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age: ≥ 16
  • Patients treated for bone metastasis in thoracic, abdominal and pelvic region
  • Patients have read, understood and signed the informed consent of the COMFORT study (in Dutch).

You may not qualify if:

  • Patients not willing or able to test two mattresses (RT-Comfort Mattress and standard thin foam matt)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erasmus MC Cancer Institute

Rotterdam, South Holland, Postbus 2040 / 3000 CA, Netherlands

Location

MeSH Terms

Conditions

NeoplasmsPain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Remi Nout, Proffessor

    Erasmus MC Cancer Institute

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 21, 2025

First Posted

March 30, 2025

Study Start

August 3, 2023

Primary Completion

December 7, 2023

Study Completion

December 7, 2023

Last Updated

March 30, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

According to the IRB approved study protocol, collected data will not be exchanged, shared or transferred outside the Erasmus MC. All data is handled conform the Dutch Act on Implementation of the General Data Protection Regulation (in Dutch: Uitvoeringswet Algemene Verordening Gegevensbescherming (UAVG)) and the Erasmus MC privacy regulations. For sharing of data with other parties patients need to be informed and they should agree for that as part of the informed consent procedure. The patients included in this study did not provide written informed consent for sharing of their data with other parties as data sharing with others was not included in the patient information folder.

Locations